STOCKHOLM, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Syncron, a global leader in intelligent aftermarket Service Lifecycle Management (SLM) solutions, today…
Treatment with casdatifan, a HIF-2a inhibitor, plus cabozantinib, a tyrosine kinase inhibitor, showed a confirmed overall response rate (ORR) of…